Functionalization of polysulfide nanoparticles and their performance as circulating carriers

被引:42
作者
Rehor, Annemie [2 ]
Schmoekel, Hugo [2 ]
Tirelli, Nicola [1 ]
Hubbell, Jeffrey A. [2 ]
机构
[1] Univ Manchester, Lab Polymers & Biomat, Sch Pharm & Pharmacal Sci, Manchester M13 9PT, Lancs, England
[2] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Lab Regenerat Med & Pharmacobiol, Integrat Biosci Inst, CH-1110 Lausanne, Switzerland
基金
英国生物技术与生命科学研究理事会;
关键词
nanoparticles; biofunctionalization; labeling; phagocytosis; macrophages;
D O I
10.1016/j.biomaterials.2007.12.035
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
We here present an evaluation of the carrier performance of nanoparticles that are biofunctional, i.e. derivatized to provide a controlled biological activity, and environmentally responsive, since they respond to the presence of oxidants. In particular, we focus on the possibilities (a) to make the nanoparticles detectable and (b) to control their uptake in phagocytic cells, which determines their lifetime in vivo. We first describe techniques for labeling selectively the nanoparticle surface or bulk with imaging moieties (fluorophores or gold). We then show how surface composition and size, which are both controlled through the use of PEG derivatives, influence uptake by macrophages in vitro and blood circulation in vivo: for example, in vitro uptake is negligible for small (40 nm) particles but not for larger (100 nm) ones and, correspondingly, in vivo blood circulation half-life time decreases from 6.0 to 2.9 h. However, upon decoration with RGD peptides also the small particles can be significantly internalized. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1958 / 1966
页数:9
相关论文
共 25 条
[1]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[2]   Chemisorbed poly(propylene sulphide)-based copolymers resist biomolecular interactions [J].
Bearinger, JP ;
Terrettaz, S ;
Michel, R ;
Tirelli, N ;
Vogel, H ;
Textor, M ;
Hubbell, JA .
NATURE MATERIALS, 2003, 2 (04) :259-264
[3]   Nanoparticle and targeted systems for cancer therapy [J].
Brannon-Peppas, L ;
Blanchette, JO .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (11) :1649-1659
[4]   PEGylated antibodies and antibody fragments for improved therapy: a review [J].
Chapman, AP .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (04) :531-545
[5]   Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer [J].
Charrois, GJR ;
Allen, TM .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2004, 1663 (1-2) :167-177
[6]   Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells [J].
Coopman, PJ ;
Thomas, DM ;
Gehlsen, KR ;
Mueller, SC .
MOLECULAR BIOLOGY OF THE CELL, 1996, 7 (11) :1789-1804
[7]  
COWENS JW, 1993, CANCER RES, V53, P2796
[8]   The dawning era of polymer therapeutics [J].
Duncan, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :347-360
[9]   Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate [J].
Faraasen, S ;
Vörös, J ;
Csúcs, G ;
Textor, M ;
Merkle, HP ;
Walter, E .
PHARMACEUTICAL RESEARCH, 2003, 20 (02) :237-246
[10]   THE STRUCTURE OF THE SINUS WALL OF THE LYMPH-NODE RELATIVE TO ITS ENDOCYTIC PROPERTIES AND TRANSMURAL CELL PASSAGE [J].
FARR, AG ;
CHO, Y ;
DEBRUYN, PPH .
AMERICAN JOURNAL OF ANATOMY, 1980, 157 (03) :265-284